Systemic lupus erythematosus: When to refer?

Hong Kong Practitioner

Volumn 24, Issue 9, 2002, Pages 444-449

  Mok, C C ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0036756387     PISSN: 10273948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ho CTK, Mok CC, Lau CS, et al. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998;57:437-440.
2. Mak SK, Lam EK, Wong AK. Clinical profile of patients with late-onset SLE: not a benign subgroup. Lupus 1998;7:23-28.
3. Klippel JH, editor. Primer on the rheumatic diseases. 11th ed. Atlanta: Arthritis Foundation, 1997.
4. Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby 1998.
5. Hochberg MC. The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus. 5th ed. Baltimore: Williams & Wilkins. 1997:49-65.
6. Mok CC, Lee KW, Ho CTK, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 2000:39:399-406.
7. Mok CC. An overview of systemic lupus erythematosus in Hong Kong. Part 1: clinical manifestations and immunogenetics. Hong Kong Bulletin on Rheumatic Diseases 2001;1:3-7.
8. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996;35:248-254.
9. Ho CTK, Mok CC, Wong RWS, et al. ACR/SLICC damage scores in an inception cohort of patients with systemic lupus erythematosus and their relationship with disease flares and other clinical variables. [abstract] American College of Rheumatology meeting 2000;abstract 1096.
10. Urowitz MB, Gladman DD. How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology (Oxford) 2000;39:238-244.
11. Mok CC, Wong RWS. Pregnancy in systemic lupus erythematosus. Postgrad Med J 2001;77:157-165.
12. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 1999;42:1785-1796.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythtosus [letter]. Arthritis Rheum 1997;40:1725.
14. Weinstein A, Bordwell B, Stone B, et al. Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus. Am J Med 1983;74:206-216.
15. Perez-Gutthann S, Petri M, Hochberg MC. Comparison of different methods of classifying patients with systemilupus erythematosus. J Rheumatol 1991; 18:1176-1179.
16. Swaak AJ, van de Brink H, Smeenk RJ, et al. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology (Oxford) 2001;40:89-94.
17. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994;21:1468-1471.
18. Ward MM, Marx AS, Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 2000;27:664-670.
19. Mok CC, Lau CS. Management strategy for systemic lupus erythematosus. HK Pract 1996;18:475-480.
20. Chau SY, Mok CC. Management of mild systemic lupus erythematosus. HK Pract 2002;24:34-39.